Categories Finance, Retail

Thanksgiving transactions: Three major deals announced this week

The week of Thanksgiving started off in a pretty interesting way. Three major deals were announced on Monday alone. Let’s take a look at them:

Viagogo-StubHub

eBay (NASDAQ: EBAY) announced the sale of its ticketing business StubHub to Viagogo for $4.05 billion in cash. Viagogo is a Switzerland-based ticket marketplace and this deal provides both companies the opportunity to do business across more than 70 countries. The sale is expected to close by the end of the first quarter of 2020, subject to regulatory conditions.

LVMH-Tiffany

Prominent luxury group LVMH Moet Hennessy Louis Vuitton SE (LVMH) announced an agreement to acquire luxury jeweller Tiffany & Co. (NYSE: TIF) for approx. EUR14.7 billion, or $16.2 billion. The transaction amounts to $135 per share in cash and is expected to close in the middle of 2020, subject to approvals and conditions. The deal is expected to strengthen LVMH’s watches and jewelry business and broaden the company’s presence in the US.

Also read: eBay (EBAY) gains after $4-Bil deal with Swiss firm Viagogo to sell StubHub

Charles Schwab-TD Ameritrade

The Charles Schwab Corporation (NYSE: SCHW) announced an agreement to acquire TD Ameritrade in an all-stock transaction valued at approx. $26 billion. As per the agreement, TD Ameritrade stockholders will receive 1.0837 Schwab shares for each TD Ameritrade share, which represents a 17% premium over the 30-day volume weighted average price exchange ratio as of November 20, 2019.

The transaction is expected to close in the second half of 2020 and is estimated to be 10-15% accretive to GAAP EPS and 15-20% accretive to operating cash EPS in the third year following the close of the deal.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top